Icosavax

YTD

ALL

Why Robinhood?

You can watch Icosavax and buy or sell other stocks, options, and ETFs commission-free!

About ICVX

Icosavax is a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases. Icosavax’s VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens, which it believes will induce broad, robust, and durable protection against the specific viruses targeted.

CEO

Adam K. Simpson

CEOAdam K. Simpson

Employees

—

Employees—

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2017

Founded2017

Employees

—

Employees—

ICVX Key Statistics

Market cap

766.86M

Market cap766.86M

Price-Earnings ratio

-6.89

Price-Earnings ratio-6.89

Dividend yield

—

Dividend yield—

Average volume

1.04M

Average volume1.04M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$16.11

52 Week high$16.11

52 Week low

$4.75

52 Week low$4.75